Fort Worth, TX · Founded 2017 · Privately Held (backing)
Operator of a biotechnology company intended to offer treatments for retinitis pigmentosa and other ophthalmological disorders. Nacuity Pharmaceuticals is based in Fort Worth, TX and was founded in 2017. Its last reported valuation was $52 million in Jun 2022. It has raised $40.6 million across 4 recorded rounds; the latest was an $8.4 million early-stage round in Dec 2025.
Last reported valuation
$52.0M
Oct 2026
Priced at
—
Total raised
$40.6M
Last round
Early Stage VC
Dec 2025
Cap table — not yet on record
Nacuity Pharmaceuticals's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Nacuity Pharmaceuticals with a free account
·Watch Nacuity Pharmaceuticals: the Monday email on marks, rounds and moves
Where does Nacuity Pharmaceuticals's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Nacuity Pharmaceuticals's 4 recorded funding rounds.
